SCHEMBL4631064

SCHEMBL4631064

Cc1cccc(-c2cc[c]cc2C(N)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 2/20 0.45
PARP1 P09874 1/20 0.44
DHODH Q02127 1/20 0.43
CDC7 O00311 1/20 0.43
SLC9A1 P19634 2/20 0.40
BCAT2 O15382 1/20 0.40
CNR2 P34972 1/20 0.40
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
ICMT O60725 1/20 0.38
RIPK2 O43353 1/20 0.38
KMO O15229 1/20 0.38
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
AKR1C3 P42330 1/20 0.37
AKR1C2 P52895 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16719394 0.84 IKBKB (0.44) PARP1BCAT2AKR1C3AKR1C2
SCHEMBL3165969 0.84 BAZ2B (0.44) PARP1DHODHBCAT2RAB9ABRD4
SCHEMBL4916850 0.83 PARP1 (0.49) PARP1CDC7SLC9A1HSD17B10ALDH1A1
SCHEMBL4638595 0.82 HPGDS (0.46) PARP1CDC7SLC9A1BCAT2KMO
SCHEMBL2637648 0.81 BCAT2 (0.61) PARP1BCAT2HSD17B10L3MBTL1ALDH1A1
SCHEMBL4654908 0.80 PI4K2A (0.52) PARP1DHODHHSD17B10ALDH1A1KDM4E
SCHEMBL6667275 0.80 BCAT2 (0.65) TLR8PARP1DHODHCDC7SLC9A1
SCHEMBL7113271 0.79 IKBKB (0.56) MAPTBRD4
SCHEMBL29723862 0.78 PARP1 (0.52) TLR8PARP1DHODHCDC7SLC9A1
SCHEMBL2784443 0.78 SLC9A1 (0.38) PARP1SLC9A1HSD17B10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP claimed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO claimed
EP-1919875-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS Astex Therapeutics Limited (GB) 2008-05-14 EP disclosed
WO-2006136829-A2 PYRAZOLE DERIVATIVES AND THEIR USE AS PKA AND PKB MODULATORS ASTEX THERAPEUTICS LIMITED (GB) 2006-12-28 WO disclosed